Iran's medication costs hinder patient treatment
Iran is facing an escalating crisis in its pharmaceutical sector due to rising prices and shortages of many essential medicines, leading to delays or interruptions in patient treatments, especially for cancer and diabetes patients. Drug prices have soared to unprecedented levels, with the cost of certain medications, such as those for Alzheimer's and antibiotics, increasing by over 300%. Meanwhile, the healthcare system is suffering from a shortage of about 43 medicines out of roughly a thousand pharmaceutical substances, primarily due to the devaluation of the currency and financial transfer restrictions resulting from sanctions. This situation is deteriorating patients' health conditions, with increasing instances of treatment refusal and declining chances of recovery, posing a significant threat to the lives of those requiring ongoing and essential treatments.
Notice: This Is an AI-Generated Summary
Comments (0)